AUS
NZ
UK
CA
USA
IND
Healthcare
Haleon Shares in Focus as FTSE 100 and FTSE 350 Healthcare Sector Reacts
March 24, 2026 05:47 PM GMT| By Vivek SinghHaleon records director share activity as consumer healthcare trends and FTSE 100 and FTSE 350 dynamics influence UK equity market behaviour.
Is GSK shaping FTSE 100 presence?
March 24, 2026 04:47 PM GMT| By Team Kalkine MediaGSK continues structured share admissions linked to employee schemes, reinforcing corporate alignment within the UK pharmaceutical sector and maintaining its presence in a major FTSE index
Is Spire Healthcare in FTSE 350 steady?
March 24, 2026 03:21 PM GMT| By Vivek SinghSpire Healthcare operates within the United Kingdom healthcare sector, balancing service delivery, operational commitments, and its position within a recognised market index.
EKF Diagnostics (LSE:EKF) Shares Move After Q Results in FTSE 350
March 24, 2026 12:11 PM GMT| By Anmol KhazanchiEKF Diagnostics performance reflects FTSE 350 dynamics, highlighting diagnostic services, global manufacturing presence, and healthcare sector activity across diverse international markets.
AstraZeneca’s (LSE:AZN) Market Movement: What It Means for Healthcare Investors
March 24, 2026 11:14 AM GMT| By Vivek SinghExplore AstraZeneca’s recent market movement and how it reflects broader trends in the healthcare sector and major UK stock indices.
Hemogenyx Pharmaceuticals (LSE:HEMO) Market Movement Within FTSE Structure
March 24, 2026 10:52 AM GMT| By Vivek SinghHemogenyx Pharmaceuticals reflects active market movement within FTSE framework, highlighting biotechnology sector activity across UK equities.
Spire Healthcare Group Plc (LSE:SPI) Falls as FTSE 350 Takeover Talks End
March 24, 2026 07:36 AM GMT| By Vivek SinghSpire Healthcare’s position in the FTSE 350 reflects its healthcare network, recent takeover developments, and evolving market activity within the United Kingdom’s private medical services landscape.
AstraZeneca (LSE:AZN) Shares Move with FTSE 100 Trends
March 23, 2026 08:16 AM GMT| By Vivek SinghComprehensive look at AstraZeneca (LSE:AZN) in the FTSE 100, covering research, manufacturing, product portfolio, regulatory compliance, and global operations within the pharmaceutical sector.
FTSE Healthcare Update: Oxford BioDynamics Activity in Focus
March 23, 2026 06:14 AM GMT| By Vivek SinghOxford BioDynamics reflects activity within the FTSE framework, highlighting developments in biotechnology, genomic diagnostics, and healthcare innovation.
Is FTSE AIM 100 Index Signalling Change?
March 22, 2026 02:01 PM GMT| By Team Kalkine MediaDiagnostics firm activity within the UK market draws attention as EKF Diagnostics reflects technical movement, insider engagement, and sector relevance within the AIM landscape.
Is FTSE AIM 100 Index Signalling Change?
March 22, 2026 07:23 AM GMT| By Team Kalkine MediaDiagnostics firm activity within the UK market draws attention as EKF Diagnostics reflects technical movement, insider engagement, and sector relevance within the AIM landscape.
Is FTSE AIM 100 shifting sentiment?
March 22, 2026 05:33 AM GMT| By Vivek SinghHealthcare sterilisation companies remain central within UK markets, with Tristel positioned in the FTSE AIM index reflecting specialised operational focus and sector relevance.
AstraZeneca Drives Healthcare Momentum in FTSE 100 Today
March 20, 2026 12:52 PM GMT| By Vivek SinghAstraZeneca (LSE:AZN) remains central to UK healthcare equities, with regulatory updates and global operations influencing its role across FTSE indices.
FTSE 100 AstraZeneca share admission signals market momentum
March 20, 2026 12:46 PM GMT| By Vivek SinghA leading pharmaceutical company expands its share base, reflecting governance strength, market transparency, and evolving capital strategies within the UK’s premier stock market landscape.
Is FTSE 100 Watching Waters?
March 20, 2026 12:25 PM GMT| By Team Kalkine MediaWaters Corporation reflects ongoing developments in the medical instruments sector, with institutional activity and financing actions aligning with broader themes observed across UK market indices.
Avacta Group (LSE:AVCT) Shares Rise Above Key FTSE 350 Indicator
March 20, 2026 09:55 AM GMT| By Vivek SinghAvacta Group activity in FTSE 350 reflects biotechnology research, targeted drug delivery innovation, and share movement influenced by clinical progress and evolving healthcare sector dynamics.
Animalcare Group (LSE:ANCR) Falls Below Key Average in FTSE 350
March 20, 2026 09:40 AM GMT| By Vivek SinghAnimalcare Group reflects trading changes within the FTSE 350 Companies segment, focusing on veterinary healthcare, pharmaceutical development, and evolving trends in animal health markets.
HUTCHMED (LSE:HCM) Falls Below Key Average in FTSE AIM 100
March 20, 2026 08:42 AM GMT| By Vivek SinghHUTCHMED’s presence in the ftse aim 100 reflects advancements in oncology research, integrated pharmaceutical operations, and evolving market activity within the global biotechnology sector.
Healthcare Sector Movements Across FTSE 350
March 20, 2026 07:36 AM GMT| By Team Kalkine MediaHealthcare sector dynamics and institutional commentary shape the narrative around a major UK medical technology company within the FTSE index landscape.
Is FTSE 100 Pharma Stability Holding
March 18, 2026 04:29 PM GMT| By Team Kalkine MediaHighlights,Pharmaceutical sector dynamics continue shaping AstraZeneca’s role in UK markets,Global healthcare demand reinforces the company’s operational footprint,Index positioning reflects broader trends within the UK equity environment,The pharmac...
